| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,360 | 7,274 | 7,000 | 7,313 | | Cost of Revenue | (3,034) | (3,422) | 6,456 | 16,547 | | | Gross Profit | 8,394 | 10,696 | 544 | (9,234) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,300 | 11,154 | 1,920 | (7,284) | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,906) | (458) | (1,376) | (1,950) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,291) | 986 | (532) | (1,938) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,291) | 986 | (532) | (1,938) | | Income Tax Expense | (840) | 422 | (200) | (669) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,452 | 564 | (332) | (1,269) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (451) | 564 | (332) | (1,269) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($451) | $564 | ($332) | ($1,269) |
|
0.03% Nasdaq 
Income Statement
